This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Washington Post
washingtonpost.com
did:plc:k5nskatzhyxersjilvtnz4lh
The FDA granted “expanded access” to a promising pancreatic cancer drug, allowing it to be given to a wider population of patients while it remains under regulatory review.
The agency said it recognizes the dire need for a drug to fight the disease.
https://www.washingtonpost.com/health/2026/05/01/pancreatic-cancer-fda-revolution-medicines/?utm_campaign=wp_main&utm_source=bluesky&utm_medium=social
2026-05-01T22:30:06.265Z